Publication:
Importance of Performing Radiotherapy and Chemotherapy in the Same Clinic and Bad Prognostic Factors for Small-cell Lung Cancer Patients

Simple item page
dc.contributor.authorKIZILTAN, HURİYE ŞENAY
dc.contributor.authorMAYADAĞLI, ALPASLAN
dc.contributor.authorTAŞTEKİN, DİDEM
dc.contributor.authorTAŞPINAR, ÖZGÜR
dc.contributor.authorERİŞ, ALİ HİKMET
dc.contributor.authorISMAYLOVA, MEDİNA
dc.contributor.institutionauthorKIZILTAN, HURİYE ŞENAY
dc.contributor.institutionauthorMAYADAĞLI, ALPASLAN
dc.contributor.institutionauthorERİŞ, ALİ HİKMET
dc.date.accessioned2019-10-05T23:16:19Z
dc.date.available2019-10-05T23:16:19Z
dc.date.issued2016-01-01
dc.description.abstractObjective: We evaluated different treatment results reported and showed the effect of treatment at single and multiple clinics for small-cell lung cancer (SCLC). We attempted to show a decreasing impact of chemotherapy (CT) and thoracic radiotherapy (RT) treatment results when implemented at different clinics for SCLC compared to the treatment results at a clinic. Methods: We conducted a retrospective study on 54 non-metastatic SCLC patients who underwent treatments at various clinics. Patients underwent 1–12 courses of CT before they came to the clinic for thoracic RT. RT was performed at 180–400 cGy dose per fraction for a total of 30–52 Gy doses, and patients were followed for 12–60 months. Results: When the study was reviewed, the results showed that the median disease-free survival and survival rates were 8 and 9 months and that the 2-, 5-, and 5-year survival rates were 8%, 6.3%, and 1.8%, respectively. The median progression-free survival rates for 2 and 3 years were 4%, and for 5 years, it was 1.8%. Weight loss for disease-free survival (p=0.01) and superior vena cava syndrome for overall survival (p=0.02) were considered as bad prognostic factors. In this study, acceptable toxicity values were found when the results were compared with those from other studies. Conclusion: We obtained worse results than those from literature data on our SCLC patients who came to our clinic after the progression of their disease. The main causes were identified as insufficient staging and different treatment protocols applied at different clinics. Therefore, we argue that CT and thoracic RT for SCLC must be performed at the same clinic and that the same protocols and staging methods must be used.
dc.identifier10.1002/pola.24537
dc.identifier.citationKIZILTAN H. Ş. , MAYADAĞLI A., TAŞTEKİN D., TAŞPINAR Ö., ERİŞ A. H. , ISMAYLOVA M., -Importance of Performing Radiotherapy and Chemotherapy in the Same Clinic and Bad Prognostic Factors for Small-cell Lung Cancer Patients-, Bezmiâlem Science, cilt.2, ss.51-5, 2016
dc.identifier.urihttps://hdl.handle.net/20.500.12645/9865
dc.identifier.wosWOS:000388331900004
dc.language.isoen
dc.subjectchemoradiotherapy
dc.titleImportance of Performing Radiotherapy and Chemotherapy in the Same Clinic and Bad Prognostic Factors for Small-cell Lung Cancer Patients
dc.typeArticle
dspace.entity.typePublication
local.article.journalnameJOURNAL OF POLYMER SCIENCE PART A-POLYMER CHEMISTRY
local.avesis.idf5f0b18b-3a74-41f0-94b7-53107ab7eda6
local.avesis.response9739
local.publication.goal03 - Sağlık ve Kaliteli Yaşam
relation.isAuthorOfPublication91868cfc-cd33-4b57-98b2-792bfc24eedb
relation.isAuthorOfPublication3f87e3db-e55d-48a8-b15f-c4f4d75c7839
relation.isAuthorOfPublicationb64c5e89-2a6e-4d0f-bdab-ff902eba9f0a
relation.isAuthorOfPublication.latestForDiscovery3f87e3db-e55d-48a8-b15f-c4f4d75c7839
relation.isGoalOfPublication9c198c48-b603-4e2f-8366-04edcfc1224c
relation.isGoalOfPublication.latestForDiscovery9c198c48-b603-4e2f-8366-04edcfc1224c
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
Importance of Performing Radiotherapy and Chemotherapy.pdf
Size:
129.7 KB
Format:
Adobe Portable Document Format
Description:
Download
Collections
Bezmialem Science Koleksiyonu
Tıp Fakültesi